Pfizer (PFE) Retained Earnings (2016 - 2025)
Pfizer (PFE) has disclosed Retained Earnings for 17 consecutive years, with -$8.1 billion as the latest value for Q4 2025.
- Quarterly Retained Earnings fell 106.91% to -$8.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$8.1 billion through Dec 2025, down 106.91% year-over-year, with the annual reading at -$8.1 billion for FY2025, 106.91% down from the prior year.
- Retained Earnings for Q4 2025 was -$8.1 billion at Pfizer, roughly flat from -$8.1 billion in the prior quarter.
- The five-year high for Retained Earnings was $131.1 billion in Q2 2023, with the low at -$8.6 billion in Q1 2025.
- Average Retained Earnings over 5 years is $60.1 billion, with a median of $95.8 billion recorded in 2021.
- The sharpest move saw Retained Earnings skyrocketed 2229.32% in 2023, then tumbled 107.24% in 2025.
- Over 5 years, Retained Earnings stood at $103.4 billion in 2021, then rose by 21.53% to $125.7 billion in 2022, then plummeted by 106.34% to -$8.0 billion in 2023, then soared by 1566.21% to $116.7 billion in 2024, then crashed by 106.91% to -$8.1 billion in 2025.
- According to Business Quant data, Retained Earnings over the past three periods came in at -$8.1 billion, -$8.1 billion, and -$8.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.